MedPath

Asthma Action at Erie Trial

Phase 3
Completed
Conditions
Asthma
Children
Interventions
Behavioral: Community Health Worker
Behavioral: Certified asthma educator
Registration Number
NCT02481986
Lead Sponsor
University of Illinois at Chicago
Brief Summary

The Asthma Action at Erie Trial compares the current best practice in asthma self-management education (certified asthma educator services) to an integrated community health worker (CHW) home intervention in which the real-life challenges of patients and the health care system are taken fully into account. This trial will provide clarity as to the expected effect size, cost savings, and resources needed to integrate asthma CHWs into clinical practice.

Detailed Description

The Asthma Action at Erie Trial will test the ability of a community health worker (CHW) intervention with three important modifications to achieve asthma control in high-risk children. These modifications are: 1) CHWs will be integrated into both the clinical and the home setting, 2) A system for directly addressing mental health and psychosocial barriers will be provided, and 3) Participants will be provided only materials and equipment for trigger remediation that are supported by the current medical reimbursement system. To test this intervention, a two-arm behavioral randomized controlled trial (N=220) will be conducted in partnership with a federally-qualified health center (FQHC) serving a low income, minority population that is at high-risk for significant asthma morbidity. The intervention arm will receive an integrated CHW home intervention for pediatric asthma education. The comparison arm will received clinic-based certified asthma educator (AE-C) services. Primary Aim 1 is to assess the efficacy of the integrated CHW home asthma intervention, relative to clinic-based AE-C education over 12-months, as demonstrated by asthma control. Specific Aim 2 is to assess maintenance of intervention efficacy, as demonstrated by asthma control at 18 and 24 months after randomization. Specific Aim 3 is to determine the cost-effectiveness at 12-months of CHW and AE-C intervention delivery, and additional costs or savings related to asthma exacerbations at 12- and 24-months. Specific Aim 4 is to assess the efficacy of the integrated CHW home asthma intervention relative to clinic-based AE-C education, as demonstrated by asthma control, among those experiencing depression, stress, and/or a post-traumatic stress disorder.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
223
Inclusion Criteria
  • Child is a patient at Erie Family Health Center
  • Child is age 5-16 at the start of the study
  • Child lives with the index caregiver at least 5 days out of the week
  • Child has uncontrolled asthma. This is defined as a score of 1.25 or greater on the Asthma Control Questionnaire, or report of oral corticosteroid use in the past year
  • Family has a working telephone
Exclusion Criteria
  • Exclusion criteria include family not fluent in English or Spanish, family lives in temporary housing such as a shelter, caregiver does not have permanent custody of child, or child has significant developmental delays or co-morbidities that would limit their ability to participate in the program.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Community health workerCommunity Health WorkerParticipants in this arm will be offered 10 home visits in a 12-month period from community health workers (CHWs). Visits will cover a core asthma curriculum and provide social support.
Certified asthma educatorCertified asthma educatorParticipants in this arm will be offered 2 education sessions with a certified asthma educator in the clinic at start of the study and again at 6-months. These sessions will be followed by a telephone call from the certified asthma educator several weeks after the sessions.
Primary Outcome Measures
NameTimeMethod
Asthma Control Test/Childhood Asthma Control Test at 12-monthsassessed 12-months from baseline, assessed over past 4 weeks

Asthma Control Test (12 years or older) or Childhood Asthma Control Test (under 12 years old) minimum 5, maximum 27, higher score means better asthma control

Activity Limitation at 12-monthsassessed 12-months after baseline, assessed over past 14 days

Days of activity limitation over past 14 days minimum 0, maximum 14, higher means worse asthma control

Secondary Outcome Measures
NameTimeMethod
Asthma Control Questionnaire at 12-monthsassessed 12-months after baseline, prior week assessed

Asthma Control Questionnaire minimum 0, maximum 6, higher score means worse asthma control

Health Care Utilization at 12-monthsassessed 12-months after baseline, assessed from baseline to 12-months

Any ED visits or hospitalizations for asthma (each ED visit or hospitalization is a single event, ED visits that transition into hospitalizations are coded as one event)

Costs of Intervention Deliveryassessed 12-months from baseline, assessed from baseline to 12-months

This measure is the total dollars spent to deliver the intervention by arm. Costs include CHW and AE-C salaries, supervision, training costs, and intervention materials that resulted in 84 AE-visits and 722 CHW visits.

Trial Locations

Locations (1)

Erie Family Health Center

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath